Pacific Biosciences of California, Inc. (PACB) Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount

Pacific Biosciences of California, Inc. Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount

Pacific Biosciences of California, Inc. (PACB) reported Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount of $107.80 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.

Financial Statements › Expense Statement › Income Tax

us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance · last filed 2026-02-25

• Pacific Biosciences of California, Inc. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2025 was $107.80M, a 293.53% increase from fiscal 2024.
• Pacific Biosciences of California, Inc. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2024 was $27.39M, a 50.56% decline from fiscal 2023.
• Pacific Biosciences of California, Inc. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2023 was $55.41M.